BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8793602)

  • 1. Lack of pantoprazole drug interactions in man: an updated review.
    Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S31-50. PubMed ID: 8793602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of pantoprazole drug interactions in man: an updated review.
    Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
    Int J Clin Pharmacol Ther; 1996 Jun; 34(6):243-62. PubMed ID: 8793611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of pantoprazole drug interactions in man.
    Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):385-99. PubMed ID: 7981922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
    Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S67-71. PubMed ID: 8793605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
    De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S58-66. PubMed ID: 8793604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of pantoprazole in man.
    Huber R; Hartmann M; Bliesath H; Lühmann R; Steinijans VW; Zech K
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S7-16. PubMed ID: 8793599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantoprazole does not interact with nifedipine in man under steady-state conditions.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Kunz K; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S81-5. PubMed ID: 8793608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of pharmacokinetic interaction between pantoprazole and diclofenac.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Wurst W; Mascher H
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S76-80. PubMed ID: 8793607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pantoprazole lacks interaction with antipyrine in man, either by inhibition or induction.
    De Mey C; Meineke I; Steinijans VW; Huber R; Hartmann M; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):98-106. PubMed ID: 8004366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pantoprazole lacks induction of CYP1A2 activity in man.
    Hartmann M; Zech K; Bliesath H; Steinijans VW; Koch H; Wurst W; Mascher H
    Int J Clin Pharmacol Ther; 1999 Apr; 37(4):159-64. PubMed ID: 10235417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of influence of pantoprazole on the disposition kinetics of theophylline in man.
    Schulz HU; Hartmann M; Steinijans VW; Huber R; Lührmann B; Bliesath H; Wurst W
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S51-7. PubMed ID: 8793603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and drug interactions--relevant factors for the choice of a drug.
    Zech K; Steinijans VW; Huber R; Kolassa N; Radtke HW
    Int J Clin Pharmacol Ther; 1996 May; 34(1 Suppl):S3-6. PubMed ID: 8793598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of interaction between pantoprazole and digoxin at therapeutic doses in man.
    Hartmann M; Huber R; Bliesath H; Steinijans VW; Koch HJ; Wurst W; Kunz K
    Int J Clin Pharmacol Ther; 1995 Sep; 33(9):481-5. PubMed ID: 8520804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pantoprazole does not interact with the pharmacokinetics of carbamazepine.
    Huber R; Bliesath H; Hartmann M; Steinijans VW; Koch H; Mascher H; Wurst W
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):521-4. PubMed ID: 9799054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
    Andersson T
    Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pantoprazole does not interact with nifedipine in man under steady-state conditions.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Kunz K; Wurst W
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):51-5. PubMed ID: 8929746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pantoprazole has no influence on steady state pharmacokinetics and pharmacodynamics of metoprolol in healthy volunteers.
    Koch HJ; Hartmann M; Bliesath H; Huber R; Steinijans VW; Mascher H; Wurst W
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):420-3. PubMed ID: 8897078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of pantoprazole in man.
    Huber R; Hartmann M; Bliesath H; Lühmann R; Steinijans VW; Zech K
    Int J Clin Pharmacol Ther; 1996 May; 34(5):185-94. PubMed ID: 8738854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of pharmacokinetic interaction between pantoprazole and diclofenac.
    Bliesath H; Huber R; Steinijans VW; Koch HJ; Wurst W; Mascher H
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):152-6. PubMed ID: 8861733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs.
    Meyer UA
    Eur J Gastroenterol Hepatol; 1996 Oct; 8 Suppl 1():S21-5. PubMed ID: 8930576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.